Terms: = Prostate cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Treatment
12 results:
1. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
Liu W; Wang M; Wang M; Liu M
Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
[TBL] [Abstract] [Full Text] [Related]
2. Identification of hub pathways and drug candidates in gastric cancer through systems biology.
Salarikia SR; Kashkooli M; Taghipour MJ; Malekpour M; Negahdaripour M
Sci Rep; 2022 Jun; 12(1):9099. PubMed ID: 35650297
[TBL] [Abstract] [Full Text] [Related]
3. Bisphenol S promotes the progression of prostate cancer by regulating the expression of col1a1 and COL1A2.
Liu S; He B; Li H
Toxicology; 2022 Apr; 472():153178. PubMed ID: 35405288
[TBL] [Abstract] [Full Text] [Related]
4. Novel therapeutic compounds for prostate adenocarcinoma treatment: An analysis using bioinformatic approaches and the CMap database.
Li K; Fan J; Qin X; Wei Q
Medicine (Baltimore); 2020 Dec; 99(51):e23768. PubMed ID: 33371142
[TBL] [Abstract] [Full Text] [Related]
5. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of the economic burden of kidney stone disease in the UK: a retrospective cohort study with a mean follow-up of 19 years.
Geraghty RM; Cook P; Walker V; Somani BK
BJU Int; 2020 Apr; 125(4):586-594. PubMed ID: 31916369
[TBL] [Abstract] [Full Text] [Related]
7. Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized prostate cancer-A Pilot Study.
Fennessy FM; Fedorov A; Vangel MG; Mulkern RV; Tretiakova M; Lis RT; Tempany C; Taplin ME
Acad Radiol; 2020 Oct; 27(10):1432-1439. PubMed ID: 31862185
[TBL] [Abstract] [Full Text] [Related]
8. A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary.
Küronya Z; Sinkovics I; Ágoston P; Bíró K; Bodrogi I; Böde I; Dank M; Gyergyay F; Vajdics T; Kolonics Z; Nagyiványi K; Rúzsa Á; Géczi L
Pathol Oncol Res; 2017 Oct; 23(4):777-783. PubMed ID: 28074331
[TBL] [Abstract] [Full Text] [Related]
9. miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways.
Lichner Z; Ding Q; Samaan S; Saleh C; Nasser A; Al-Haddad S; Samuel JN; Fleshner NE; Stephan C; Jung K; Yousef GM
J Pathol; 2015 Oct; 237(2):226-37. PubMed ID: 26011734
[TBL] [Abstract] [Full Text] [Related]
10. Lifestyle and health factors associated with progressing and remitting trajectories of untreated lower urinary tract symptoms among elderly men.
Marshall LM; Holton KF; Parsons JK; Lapidus JA; Ramsey K; Barrett-Connor E;
Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):265-72. PubMed ID: 25000909
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of in vitro bioactivation of flutamide and its cyano analogue: evidence for reductive activation by human NADPH:cytochrome P450 reductase.
Wen B; Coe KJ; Rademacher P; Fitch WL; Monshouwer M; Nelson SD
Chem Res Toxicol; 2008 Dec; 21(12):2393-406. PubMed ID: 19548358
[TBL] [Abstract] [Full Text] [Related]
12. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy.
Kiteley RA; Lee WR; deGuzman AF; Mirzaei M; McCullough DL
Brachytherapy; 2002; 1(2):90-4. PubMed ID: 15062176
[TBL] [Abstract] [Full Text] [Related]
